Alzai Health Corp. (TSXV:ALZI)

Alzai Health Financials Overview

Financials in millions CAD. Fiscal year is May - April.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2026	FY 2025
Period Ending	Jul 31, 2026	Apr 30, 2026	Apr 30, 2025
Revenue Revenue Growth	0.07	0.03	-
Revenue Growth	-	-	-
Gross Profit Gross Profit Growth	-0.48	-0.39	-0.04
Operating Income Operating Income Growth	-4	-3.62	-1.48
Net Income Net Income Growth	-4.13	-3.68	-1.5
Earnings Per Share EPS Growth	-0.08	-0.07	-0.05
EPS Growth	-	-	-

Cash & Debt

Chart

Fiscal Year	Current	FY 2026	FY 2025
Period Ending	Jul 31, 2026	Apr 30, 2026	Apr 30, 2025
Cash & Investments Cash & Investments Growth	1.91	0.27	0.31
Total Debt Total Debt Growth	0.59	0.83	-
Net Cash (Debt) Net Cash Growth	1.32	-0.57	0.31
Net Cash Growth	-	-	-
Net Cash Per Share Net Cash Per Share Growth	0.02	-0.01	0.01

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2026	FY 2025
Period Ending	Jul 31, 2026	Apr 30, 2026	Apr 30, 2025
Operating Cash Flow Operating Cash Flow Growth	-3.73	-2.59	-1.14
Capital Expenditures CapEx Growth	-0.02	-0.02	-
Free Cash Flow Free Cash Flow Growth	-3.75	-2.61	-1.14
Free Cash Flow Growth	-	-	-

Margins

Chart

Fiscal Year	TTM	FY 2026	FY 2025
Period Ending	Jul 31, 2026	Apr 30, 2026	Apr 30, 2025
Operating Margin	-5783.60%	-13405.82%	-
Pretax Margin	-5981.44%	-13593.12%	-
Profit Margin	-5981.44%	-13593.12%	-
FCF Margin	-5421.93%	-9653.91%	-

Data Source: S&P Global Market Intelligence Last updated: Sep 29, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 7, 2026

Data Sources Report a data error